Your session is about to expire
← Back to Search
μCor for Heart Failure (BMAD-TX Trial)
N/A
Waitlist Available
Research Sponsored by Zoll Medical Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 2.5 years.
Awards & highlights
BMAD-TX Trial Summary
This trial is testing how well a new system, which includes a sensor and wearable patch, helps manage heart failure.
BMAD-TX Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 2.5 years.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 2.5 years.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Investigator Engagement of Device Data
Secondary outcome measures
Correlations of cardiac rhythm μCor measurements and heart failure related symptoms.
Correlations of cardiac rhythm μCor measurements to heart failure related clinical events.
Correlations of respiration rate μCor measurements and heart failure related symptoms.
+15 moreBMAD-TX Trial Design
1Treatment groups
Experimental Treatment
Group I: Device Data Engagement AssessmentExperimental Treatment1 Intervention
This arm will assess the endpoints of investigator engagement with the device data.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
μCor
2019
N/A
~270
Find a Location
Who is running the clinical trial?
Zoll Medical CorporationLead Sponsor
41 Previous Clinical Trials
21,714 Total Patients Enrolled
13 Trials studying Heart Failure
3,501 Patients Enrolled for Heart Failure
Mike OszStudy DirectorZoll Medical Corporation
3 Previous Clinical Trials
733 Total Patients Enrolled
3 Trials studying Heart Failure
733 Patients Enrolled for Heart Failure
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a skin allergy or sensitivity to medical adhesives.You currently have a device called an LVAD implanted in your body.You have a non-heart condition that is expected to shorten your life to less than one year.
Research Study Groups:
This trial has the following groups:- Group 1: Device Data Engagement Assessment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger